Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Feb-24 2:16 PM View:  | Israel Biotech Fund I, L.P. Director 10% Owner | Advaxis Inc. (ADXS) | 07-Feb-24 | Option Exercise | 27,847,200 | $0.40 | $11,138,900.00 | 120% 23.24M to 51.09M | |
| 12-Feb-24 2:16 PM View: | Israel Biotech Fund I, L.P. Director 10% Owner | Advaxis Inc. (ADXS) | 07-Feb-24 | Payment of Exercise | 5,294,490 | $1.25 | $6,599,580.00 | (10%) 51.09M to 45.79M | |
| 23-Oct-23 6:43 AM View: | Amoon 2 Fund Limited Partne... 10% Owner | Advaxis Inc. (ADXS) | 18-Oct-23 | Disposition (other) | -- | -- | -- | 0% 560.6K | |
| 31-Oct-23 7:08 AM View: | Israel Biotech Fund I, L.P. 10% Owner | Advaxis Inc. (ADXS) | 18-Oct-23 | Purchase | 1,317,720 | -- | -- | 56% 2.36M to 3.68M | |
| 23-Jan-23 6:19 PM View: | Sidransky David Director | Advaxis Inc. (ADXS) | 19-Jan-23 | Grant | 46 | -- | -- | 49% 93 to 0.14K | |
| 16-Mar-20 5:00 PM View: | Appel Roni Director | Advaxis Inc. (ADXS) | 13-Mar-20 | Market Sale | 2,401 | $0.55 | $1,320.55 | (19%) 12.88K to 10.48K | (22%) |
| 16-Mar-20 5:00 PM View: | Appel Roni Director | Advaxis Inc. (ADXS) | 12-Mar-20 | Market Sale | 200 | $0.58 | $116.00 | (2%) 13.08K to 12.88K | (17%) |
| 16-Mar-20 5:00 PM View: | Appel Roni Director | Advaxis Inc. (ADXS) | 11-Mar-20 | Market Sale | 399 | $0.67 | $267.33 | (3%) 13.48K to 13.08K | (1%) |
| 11-Apr-19 12:11 PM View: | Henderson Molly Executive Vice President & CFO | Advaxis Inc. (ADXS) | 11-Apr-19 | Grant | 2,500 | $3.68 | $9,199.75 | 75% 3.33K to 5.83K | (82%) |
| 11-Apr-19 5:11 PM View: | Gutierrez Andres Executive Vice President & CMO | Advaxis Inc. (ADXS) | 11-Apr-19 | Grant | 3,750 | $3.71 | $13,928.20 | 100% 0 to 3.75K | (82%) |
| 11-Apr-19 12:11 PM View: | Appel Roni Director | Advaxis Inc. (ADXS) | 10-Apr-19 | Market Purchase | 3,000 | $3.80 | $11,391.00 | 29% 10.48K to 13.48K | (83%) |
| 07-Nov-18 5:00 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 05-Nov-18 | Market Sale | 3,963 | $0.58 | $2,298.54 | (2%) 235.17K to 231.21K | 93% |
| 05-Nov-18 6:00 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 02-Nov-18 | Market Sale | 8,491 | $0.56 | $4,754.96 | (3%) 243.66K to 235.17K | 93% |
| 13-Sep-18 4:30 PM View: | Appel Roni Director | Advaxis Inc. (ADXS) | 11-Sep-18 | Purchase | 33,333 | $1.20 | $39,999.60 | 27% 123.81K to 157.14K | |
| 01-Aug-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 31-Jul-18 | Grant | 1,505 | $1.46 | $2,197.30 | < 1% 242.16K to 243.66K | (97%) |
| 02-Jul-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 29-Jun-18 | Grant | 1,516 | $1.45 | $2,198.20 | < 1% 240.64K to 242.16K | (97%) |
| 27-Jun-18 5:15 PM View: | Patton James P Director | Advaxis Inc. (ADXS) | 26-Jun-18 | Grant | 25,000 | -- | -- | 10% 261.75K to 286.75K | |
| 27-Jun-18 5:15 PM View: | Sidransky David Director | Advaxis Inc. (ADXS) | 26-Jun-18 | Grant | 15,000 | -- | -- | 16% 95.36K to 110.36K | |
| 27-Jun-18 5:15 PM View: | Berman Richard J Director | Advaxis Inc. (ADXS) | 26-Jun-18 | Grant | 5,000 | -- | -- | 10% 50.67K to 55.67K | |
| 02-Jul-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 18-Jun-18 | Grant | 9,000 | $1.72 | $15,480.00 | 4% 231.64K to 240.64K | (98%) |
| 14-Jun-18 4:30 PM View: | Sidransky David Director | Advaxis Inc. (ADXS) | 13-Jun-18 | Grant | 5,000 | $1.71 | $8,550.00 | 6% 90.36K to 95.36K | (98%) |
| 13-Jun-18 6:37 PM View: | Henderson Molly Executive Vice President & CFO | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 5,000 | $1.89 | $9,450.00 | 100% 0 to 5.0K | (98%) |
| 13-Jun-18 6:36 PM View: | Patton James P Director | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 50,000 | $1.84 | $92,000.00 | 24% 211.75K to 261.75K | (98%) |
| 02-Jul-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 5,000 | $1.84 | $9,200.00 | 2% 226.64K to 231.64K | (98%) |
| 13-Jun-18 7:29 PM View: | Berlin Kenneth A President & CEO Director | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 15,000 | $1.84 | $27,600.00 | 6% 250.0K to 265.0K | (98%) |
| 13-Jun-18 6:36 PM View: | Sidransky David Director | Advaxis Inc. (ADXS) | 12-Jun-18 | Grant | 10,000 | $1.84 | $18,432.00 | 12% 80.36K to 90.36K | (98%) |
| 01-Jun-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 31-May-18 | Grant | 1,765 | $1.82 | $3,212.30 | < 1% 224.87K to 226.64K | (98%) |
| 02-May-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 30-Apr-18 | Grant | 1,374 | $1.60 | $2,198.40 | < 1% 223.5K to 224.87K | (97%) |
| 25-Apr-18 4:45 PM View: | Berlin Kenneth A President & CEO Director | Advaxis Inc. (ADXS) | 23-Apr-18 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 18-Apr-18 4:30 PM View: | Lombardo Anthony A Interim CEO | Advaxis Inc. (ADXS) | 17-Apr-18 | Payment of Exercise | 11,051 | $1.70 | $18,786.70 | (12%) 92.9K to 81.85K | 98% |
| 03-Apr-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 02-Apr-18 | Market Sale | 2,193 | $1.62 | $3,552.66 | (< 1%) 225.69K to 223.5K | 98% |
| 03-Apr-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 29-Mar-18 | Grant | 1,111 | $1.69 | $1,877.59 | < 1% 224.58K to 225.69K | (98%) |
| 03-Apr-18 4:30 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 29-Mar-18 | Grant | 1,088 | $1.69 | $1,838.72 | < 1% 225.58K to 226.67K | (98%) |
| 01-Mar-18 10:00 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 28-Feb-18 | Grant | 989 | $1.86 | $1,839.54 | < 1% 224.59K to 225.58K | (98%) |
| 01-Mar-18 10:00 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 28-Feb-18 | Grant | 1,182 | $1.86 | $2,198.52 | < 1% 223.4K to 224.58K | (98%) |
| 02-Feb-18 4:30 PM View: | Lombardo Anthony A Interim CEO | Advaxis Inc. (ADXS) | 02-Feb-18 | Market Sale | 32 | $2.93 | $93.76 | (< 1%) 92.94K to 92.9K | 99% |
| 02-Feb-18 4:30 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 31-Jan-18 | Grant | 580 | $2.96 | $1,716.80 | (< 1%) 225.17K to 224.59K | 99% |
| 02-Feb-18 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 31-Jan-18 | Grant | 696 | $2.96 | $2,060.16 | < 1% 222.7K to 223.4K | (99%) |
| 03-Jan-18 6:00 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 03-Jan-18 | Market Sale | 5,224 | $3.18 | $16,612.30 | (2%) 229.24K to 224.01K | 99% |
| 03-Jan-18 6:00 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 29-Dec-17 | Grant | 752 | $2.84 | $2,135.68 | < 1% 221.95K to 222.7K | (99%) |
| 03-Jan-18 6:00 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 29-Dec-17 | Grant | 473 | $2.84 | $1,343.32 | < 1% 228.76K to 229.24K | (99%) |
| 04-Dec-17 4:30 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 30-Nov-17 | Grant | 856 | $2.99 | $2,559.44 | < 1% 227.91K to 228.76K | (99%) |
| 04-Dec-17 4:30 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 30-Nov-17 | Grant | 1,035 | $2.99 | $3,094.65 | < 1% 220.92K to 221.95K | (99%) |
| 06-Nov-17 6:00 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 06-Nov-17 | Market Sale | 3,723 | $3.30 | $12,285.90 | (2%) 224.64K to 220.92K | 99% |
| 06-Nov-17 6:00 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 06-Nov-17 | Market Sale | 3,862 | $3.30 | $12,744.60 | (2%) 231.77K to 227.91K | 99% |
| 02-Nov-17 5:52 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 02-Nov-17 | Market Sale | 12,734 | $3.19 | $40,621.50 | (5%) 244.5K to 231.77K | 99% |
| 02-Nov-17 6:00 PM View: | Lombardo Anthony A Interim CEO | Advaxis Inc. (ADXS) | 02-Nov-17 | Market Sale | 24 | $3.19 | $76.56 | (< 1%) 92.96K to 92.94K | 99% |
| 02-Nov-17 5:54 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 02-Nov-17 | Market Sale | 12,625 | $3.19 | $40,273.80 | (5%) 237.26K to 224.64K | 99% |
| 02-Nov-17 5:52 PM View: | Bonstein Sara Chief Financial Officer | Advaxis Inc. (ADXS) | 31-Oct-17 | Grant | 379 | $3.40 | $1,288.60 | < 1% 244.13K to 244.5K | (99%) |
| 02-Nov-17 5:54 PM View: | Petit Robert Chief Scientific Officer | Advaxis Inc. (ADXS) | 31-Oct-17 | Grant | 432 | $3.40 | $1,468.80 | < 1% 236.83K to 237.26K | (99%) |
